| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.03 |
| mRNA | NU-7441 | GDSC1000 | pan-cancer | AAC | -0.076 | 0.03 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | -0.078 | 0.03 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | -0.073 | 0.03 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.03 |
| mRNA | KIN001-244 | GDSC1000 | pan-cancer | AAC | 0.064 | 0.04 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.073 | 0.04 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | -0.063 | 0.04 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.04 |